| Gene symbol | MAGEA4 | Synonyms | CT1.4, MAGE-41, MAGE-X2, MAGE4, MAGE4A, MAGE4B | Type of gene | protein-coding |
| Chromosome | X | Map location | Xq28 | dbXrefs | |
| Description | MAGE family member A4 | ||||
| GTO ID | GTC0615 |
| Trial ID | JPRN-UMIN000002395 |
| Disease | Esophageal Cancer |
| Altered gene | MAGE-A4 |
| Therapeutic/Target gene | Target gene |
| Therapy | TCR-T cell |
| Treatment | MAGE-A4 TCR-T cells |
| Phase | Phase1 |
| Recruitment status | Not Recruiting |
| Title | Adoptive transfer of lymphocytes transduced with MAGE-A4-specific TCR gene for therapy-resistant esophageal cancer |
| Year | 2009 |
| Country | Japan |
| Company sponsor | Mie University Hospital |
| Cohort1: dose level 1 | |||||||||||||||
|
|||||||||||||||
| Cohort2: dose level 2 | |||||||||||||||
|
|||||||||||||||
| Cohort3: dose level 3 | |||||||||||||||
|
|||||||||||||||